Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Aerobic Fitness Is Associated with Better Cognitive and Motor Function in Mild-moderate Parkinson’s Disease

Author:Uc, Ergun   Comellas, Alejandro   Kline, Joel   Dawson, Jeffrey   Narayanan, Nandakumar   Rizzo, Matthew   Voss, Michelle   Anderson, Steven   Weber, Christina   Darling, Warren   

Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

Topic:Movement Disorders  

Program Number:P4.016  

Author Institution:University of Iowa/Iowa City VA Medical Center, Iowa City, IA  University of Iowa, Iowa City, IA  University of Nebraska Medical Center, Omaha, NE  

Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-mediated Autoimmune Diseases

Author:Vu, Tuan   Gwathmey, Kelly   Broome, Catherine   Goebeler, Matthias   Murai, Hiroyuki   Bata-Csörgo, Zsuzsanna   Newland, Adrian   Ulrichts, Peter   Kerstens, Rene   Guptill, Jeffrey T.   Agha, Sofiane   Jiang, Ming   Howard, James   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.016  

Author Institution:University of South Florida, Tampa, FL  Virginia Commonwealth University, Henrico, VA  Georgetown University, Washington, DC  University Hospital Würzburg, Würzburg, Germany  International University of Health and Welfare, Narita, Japan  University of Szeged, Szeged, Hungary  Barts and the London School of Medicine and Dentistry, London, United Kingdom  argenx, Boston, MA  argenx, Ghent , Belgium  argenx, Ghent, Belgium  The University of North Carolina, Dept of Neurology, CB 7025, Chapel Hill, NC  

Characteristics, Treatment Patterns, and Disease Burden of Juvenile Myasthenia Gravis in the United States

Author:Zhou, Jiachen   Nilius, Sigrid   Pilipczuk, Olga   Scowcroft, Anna   Tarancón, Thaïs   Tennigkeit, Frank   Zaremba, Piotr   Brandsema, John   Strober, Jonathan   

Session Name:P4: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P4.017  

Author Institution:UCB Pharma, Cambridge, MA, USA, Cambridge, MA  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Warsaw, Poland, Warsaw, Poland  UCB Pharma, Slough, UK, Slough, United Kingdom  UCB Pharma, Madrid, Spain, Madrid, Spain  Children’s Hospital of Philadelphia, Philadelphia, PA, USA, Philadelphia, PA  UCSF Benioff Children’s Hospital, San Francisco, CA, USA, San Francisco, CA  

Patient Characteristics and Real-world Use of Botulinum Toxins for Treatment of Chronic Sialorrhea

Author:Hast, Michael   Kong, Amanda   Abdelhadi, Jenna   Szendrey, Andrew   Shah, Rohan   Holmes, Jordan   

Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

Topic:Movement Disorders  

Program Number:P4.017  

Author Institution:Merz Pharmaceuticals LLC, Raleigh, NC  Aetion, Inc, New York, NY  

Characterizing Ligands that have Immunomodulatory Potential at the Choroid Plexus in Neurodegenerative Disease

Author:Bakshi, Bhavya   Rosenbalm, Katelyn   Tiemeyer, Michael   

Session Name:P4: Dementia and Behavioral Neurology: Non-AD Pathology 1  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:P4.017  

Author Institution:Medical College of Georgia, Atlanta, GA  University of Georgia, Athens GA, GA  University of Georgia, Athens, GA